Frat prank: Peanut butter smeared on allergic college student

Parents of children with nut allergies know it’s no laughing matter. Mr. Peanut might as well be the Grim Reaper.

So when a mother of college student Andrew Seely learned that her son had been smeared with peanut butter as a frat prank at Central Michigan University, she went to Facebook. Her post has gone viral, according to Detroit news station WINK. 

A photo of her 19-year-old son shows him with a swollen face, one eye nearly closed. The incident occurred in October at Alpha Chi Rho fraternity during his first semester. He was smeared with peanut butter while he slept.

peanut-butter-allergy-boy1-696x428
An outraged mother’says her son suffered a severe allergic reaction to peanut butter, after it was rubbed on his face while he was asleep at an off-campus fraternity back in October.

“We found out that our son was a victim of a hazing incident,” Seely wrote in a post that has since been shared by more than 1,400 people. “This is a picture of what they did to him. He has a deadly peanut allergy and they rubbed peanut butter on his face while he was passed out.”

The university and local police were contacted by the Seely family

“My heart just sank to my stomach when is saw [the photos],” Andrew’s dad, Paul Seely said.

“As time goes on, the reality sets in — he could have died. He really could have. If peanut butter had gotten into his mouth it would have been dire.”

A professor took Andrew to the campus health clinic for treatment.

“Obviously this is very concerning and we take these things very seriously,” said Heather Smith, director of communications at Central Michigan University.

Smith said the fraternity involved, Alpha Chi Rho, was officially disbanded on the campus in 2011 and are not recognized.

Andrew left the school at the end of the semester and transferred to a different school.

“He’s been very emotional about this as he understands how serious this is,” the teen’s father said. “He can’t get his head around it. It’s really affected him — he had to get away.”

Read more about the story at WINK by clicking here.

Epi-Pen crisis sends Boynton Beach mom to Canada

A Boynton Beach mother says she hopes to buy EpiPens in Canada for her 8-year-old son after the price of the life-saving product for allergies skyrocketed in the U.S. by 400 percent.

Anna Pickman’s son, Zander, has a severe food allergy that her doctor says could be fatal. “The allergy is so bad he can’t even touch anything containing milk. Just from touching it, he breaks out in hives,” she said.

960x0
Families of children with allergies s who need EpiPens have been hit with a 400 percent increase in the product.

Every school year she buys EpiPens for home and for school. This year when she went to CVS to buy them and was told that the medicine would cost $575 for one package of two (the dose is often two shots),

She thought it was $5.75.

Then when she said she needed another and the pharmacist said it would cost her total of $1,100.

“Then my jaw dropped. I don’t have $1,100 in my pocket,” Pickman said.

Pickman said in past years she has paid $100 and even nothing with a coupon and insurance. This August, her insurance said the cost was not covered because she had not met her deductible.

Heather Bresch – the CEO of Mylan, the company that makes EpiPens – has come under intense fire   surrounding the recent 400-percent increase in her company’s allergy injector that is used for peanut, milk and other food allergies, as well as for those allegeric to bee stings.

Mylan’s profits from selling EpiPens hit $1.2 billion in 2015. The drug in EpiPens is actually generic but Bloomberg reports that the epinephrine-delivery system by Mylan represented 40 percent of the company’s operating profits.

IMG_1659
Anna Pickman with her son, Zander, says she would have had to pay nearly $1,100 for EpiPens for her sons’ milk allergy.

In response to the backlash, Mylan is offering a generic EpiPen for half the price, or about $300 for a pack of two. It also has said it would increase financial assistance for uninsured patients. But the company has refused to reduce the price, meaning that either insurance or the patient ends up picking up the tab.

Pickman said she found it interesting that Bresch has received an increase in her CEO pay and that company has aggressively marketed the product.

She says there is only word to describe the EpiPen price gouging: greed.

Pickman’s husband, Sarge, will soon travel to Canada and she has done research and found that the product is far less expensive north of the border where drug costs are regulated. She hopes with prescription in hand she can get the much-needed life-saving medication for her son there.

In the meantime, she has a few EpiPens that have not expired and will rely on those until her husband heads to Canada with fingers crossed.